The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Opening of enrollment in US of Phase I CRC study announced today at

coloCan
coloCan CSN Member Posts: 1,944 Member
edited March 2014 in Colorectal Cancer #1
www.prnewswire.com

title: Oncolytics Biotech Inc Announces Opening of Enrollment in US Phase I Colorectal Cancer Study

This involves using REOLYSIN (this firm's drug) in combo with FOLFIRI for those with oxaliplatin refractory/intolerant Kras mutant CRC



Meanwhile,a company called Pro-Pharma seems to be getting positive feedback from FDA for Phase III trial design for DAVANAT, which is its CRC drug in progress.......see:businesswire.com

dont know if this will help anyone......steve
Like Care

Comments

  • Lovekitties
    Lovekitties CSN Member Posts: 3,364 Member
    #2
    Thanks Steve
    You are a gem to keep up with all the latest and greatest and keeping everyone here in the loop.

    Thanks for being you.

    Marie who loves kitties
    Like Care

Discussion Boards